These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18462378)

  • 1. Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection.
    Cross T; Antoniades C; Harrison P
    Hepatol Res; 2008 Aug; 38(8):762-9. PubMed ID: 18462378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients.
    Arabul M; Aslan F; Alper E; Akpinar Z; Çelık M; Kandemır A; Vatansever S; Ünsal B
    Turk J Gastroenterol; 2012; 23(5):538-45. PubMed ID: 23161299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive monitoring of patients with chronic hepatitis C.
    Fontana RJ; Lok AS
    Hepatology; 2002 Nov; 36(5 Suppl 1):S57-64. PubMed ID: 12407577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of fibrosis in chronic liver diseases.
    Zhou K; Lu LG
    J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of non-invasive tests for assessment of liver fibrosis.
    Patel K; Sebastiani G
    JHEP Rep; 2020 Apr; 2(2):100067. PubMed ID: 32118201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is liver biopsy still needed in children with chronic viral hepatitis?
    Pokorska-Śpiewak M; Kowalik-Mikołajewska B; Aniszewska M; Pluta M; Marczyńska M
    World J Gastroenterol; 2015 Nov; 21(42):12141-9. PubMed ID: 26576098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.
    Zeng DW; Dong J; Liu YR; Jiang JJ; Zhu YY
    World J Gastroenterol; 2016 Aug; 22(29):6663-72. PubMed ID: 27547009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-invasive diagnostic methods of fibrosis in chronic hepatitis C virus infection: their role in treatment indication, follow-up and assessment of prognosis].
    Pár A; Vincze Á; Pár G
    Orv Hetil; 2015 May; 156(21):855-61. PubMed ID: 26038993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive assessment of liver fibrosis in chronic hepatitis B.
    Branchi F; Conti CB; Baccarin A; Lampertico P; Conte D; Fraquelli M
    World J Gastroenterol; 2014 Oct; 20(40):14568-80. PubMed ID: 25356021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C? .
    Ladero JM; Cárdenas MC; Ortega L; González-Pino A; Cuenca F; Morales C; Lee-Brunner A
    Ann Hepatol; 2012; 11(5):648-51. PubMed ID: 22947524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.
    Tanwar S; Rhodes F; Srivastava A; Trembling PM; Rosenberg WM
    World J Gastroenterol; 2020 Jan; 26(2):109-133. PubMed ID: 31969775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient elastography--an alternative to liver biopsy in patients with chronic hepatitis C?
    Stanciu C; Trifan A; Cojocariu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):765-70. PubMed ID: 17438875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non invasive tools for the diagnosis of liver cirrhosis.
    Soresi M; Giannitrapani L; Cervello M; Licata A; Montalto G
    World J Gastroenterol; 2014 Dec; 20(48):18131-50. PubMed ID: 25561782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of non-invasive models for liver fibrosis in chronic hepatitis B virus related liver disease patients in resource limited settings.
    Shrivastava R; Sen S; Banerji D; Praharaj AK; Chopra GS; Gill SS
    Indian J Pathol Microbiol; 2013; 56(3):196-9. PubMed ID: 24152493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
    Bejarano G; Vergara M; Dalmau B; Puig J; Bella MR; Suárez D; Calvet X
    Rev Esp Enferm Dig; 2009 May; 101(5):325-35. PubMed ID: 19527078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process.
    Servin-Abad L; Schiff ER
    Gastroenterol Hepatol (N Y); 2006 Nov; 2(11):819-825. PubMed ID: 28381952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.